APR has crossed ₩1.5 trillion KRW (over $1B USD) in revenue — and is now expanding beyond skincare into professional-grade medical devices.

In this episode of Crying in O.Y., we break down why Medicube’s parent company is moving up the value chain, shifting from mass cosmetics into energy-based clinical equipment.

We cover:

• How APR doubled revenue year-over-year
• Why cosmetics margins eventually compress
• The economics of higher ASP through devices
• The clinic → home maintenance “treatment loop”
• The role of PDRN and longevity positioning
• What regulatory approval and hospital adoption will determine next

This isn’t product expansion. It’s margin expansion and category repositioning.

For professionals in beauty retail, brand strategy, distribution, and aesthetics.